$IBB Headlines SP 500 pulls in from less-charted

New Post Public Reply Private Reply Replies (0) Message Board

Dec 11, 2013 at 12:39 PM

$IBB Headlines

S&P 500 pulls in from less-charted territory 11:17 a.m. Today - Michael Ashbaugh
Stay the course with caution 4:04 p.m. Dec. 2, 2013 - Bill Donoghue
This backdrop is what bull markets are made of 1:58 p.m. Dec. 2, 2013 - The Trading Deck
Nasdaq Composite rattles cage on the 4,000 mark 11:29 a.m. Nov. 25, 2013 - Michael Ashbaugh
From tiny Akorns grow mighty oaks? 10:03 a.m. Nov. 21, 2013 - The Trading Deck
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
ETFs to ride the market’s peaks 11:01 p.m. Nov. 3, 2013 - Jim Lowell
Top performers’ top November bets 11:01 p.m. Nov. 3, 2013 - Mark Hulbert
Don’t let taxes eat up your portfolio 4:31 p.m. Oct. 28, 2013 - Bill Donoghue
Healthcare stocks fall from first place in race for year's best-performing sector 2:32 p.m. Oct. 24, 2013 - blogs.marketwatch.com
Gold miners, biotech among worst-performing ETFs during shutdown 3:01 p.m. Oct. 15, 2013 - blogs.marketwatch.com
Here’s what happens when institutions blink 10:41 a.m. Oct. 11, 2013 - The Trading Deck
Biotech ETF's breakout: bullish for stocks overall? 12:11 p.m. Sept. 5, 2013 - blogs.marketwatch.com
A bull market not ready to be put to rest 11:14 a.m. Sept. 5, 2013 - The Trading Deck
S&P rises within view of major technical test 10:36 a.m. Sept. 5, 2013 - Michael Ashbaugh
Charting a market divergence 10:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Doug Kass gives you 3 or more reasons to short the market 10:50 a.m. Aug. 14, 2013 - blogs.marketwatch.com
Dow presses higher, notches latest all-time high 11:14 a.m. July 31, 2013 - Michael Ashbaugh
What would Grumpy Cat short? 7:56 a.m. July 30, 2013 - The Trading Deck
Can this biotech double its price again? 7:02 a.m. July 17, 2013 - The Trading Deck

Gilead Sciences: Sovaldi Hepatitis C Pill Approved 6:25 p.m. Dec. 9, 2013 - Seeking Alpha
The 3 Best Sectors to Buy for 2014 4:59 a.m. Dec. 9, 2013 - InvestorPlace.com
Not Your Father's Diagnostics: Ram Selvaraju On How Molecular Genomics Invigorate The Sector 4:27 p.m. Dec. 6, 2013 - Seeking Alpha
Are Biotech ETFs Back on Track? - ETF News And Commentary 12:04 p.m. Dec. 4, 2013 - Zacks.com
Bear of the Day: SurModics (SRDX) - Bear of the Day 5:07 a.m. Dec. 4, 2013 - Zacks.com
Bear of the Day: SurModics (SRDX) - Bear of the Day 5:07 a.m. Dec. 4, 2013 - Zacks.com
2 Biotech Funds You Should Consider Owning For 2014 4:02 p.m. Dec. 3, 2013 - Seeking Alpha
The Big Pharma Stock Making Gains (and The One Suffering Big Losses) 11:54 a.m. Dec. 2, 2013 - TheStreet.com
Biotech Stocks With Promise 11:00 a.m. Nov. 29, 2013 - RealMoney.com
Life Sciences Offer Good Growth With Much Less Risk Than Biopharmaceuticals 11:54 a.m. Nov. 26, 2013 - Seeking Alpha
ETF Outlook for Tuesday, November 26, 2013 7:16 a.m. Nov. 26, 2013 - Benzinga.com
From Little Akorn Grows a Great Stock 6:30 a.m. Nov. 26, 2013 - TheStreet.com
Biotech Surges As Tech Struggles 1:54 a.m. Nov. 26, 2013 - Seeking Alpha
The Market's Best Sector 7:40 a.m. Nov. 15, 2013 - Seeking Alpha
'Long Only' Funds? Shorting Stocks Is So 2008 4:01 p.m. Nov. 12, 2013 - Seeking Alpha
Too Exhausted to Chase 7:30 a.m. Nov. 12, 2013 - RealMoney.com
How to Add Alpha Using Tactical ETFs 6:30 a.m. Nov. 11, 2013 - TheStreet.com
3 Best Low-Risk Biotetch Buyout Plays 5:13 a.m. Nov. 11, 2013 - InvestorPlace.com
How To Add Alpha Using Tactical ETFs 7:22 p.m. Nov. 8, 2013 - Seeking Alpha
Protect Your Investments Against a Bubble, Know What Makes a Bubble 10:28 a.m. Nov. 4, 2013 - TheStreet.com

Galectin Stands Out in 2013 with Liver Fibrosis Drug 11:06 a.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 8:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 8:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 7:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 7:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 7:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 7:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 8:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 7:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 7:40 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ANAC, RPRX, THLD and THRX 7:52 a.m. July 17, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTK, DNDN, IMGN and NVAX 7:43 a.m. July 17, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CELG, SIGA and SNTS 7:31 a.m. July 17, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GERN, IMMU and ITMN 7:48 a.m. July 2, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on EXEL, NVAX, SQNM and VVUS 7:48 a.m. July 2, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CTIC, INCY, PDLI and NPSP 7:46 a.m. July 2, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, CLDX and HALO 7:33 a.m. July 2, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CNDO, NKTR, THRX and VNDA 7:33 a.m. June 28, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CHTP, CLVS, HPTX and SGEN 7:32 a.m. June 28, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BPAX, PPHM, RPRX and SGMO 7:51 a.m. June 24, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lupin Secures FDA Nod for Key Injectable Drug

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Ingram Mercantile's Aviation Push: SCORE or Sink?

Unpacking Neobanx's Strategic Play Straight off the tarmac, Neobanx launches Ingram Mercantile, placing their bets on the aviation sector with none other than Eli Stepp at the helm. This ain't just another day in the sky for those in the know; it's part of a gutsy bid to inject some high-octane intelligence into the world of retail. I mean, have you seen the landscape...

Striveworks: Boosting Army's AI Edge in Indo-Pacific

The world keeps marching forward, and here’s Striveworks stepping up to the plate with another big move in the military tech space. This isn't your average partnership renewal; this involves a five-year, $200 million deal to enhance battlefield AI as the U.S. Army hones its modern warfare edge in the Indo-Pacific. Now, this isn't just a battle of strategies but a battle...

Icebox Takes on Buckhead with Diamonds and Discounts

So, Atlanta's Icebox Diamonds & Watches just dropped a news bomb that could shake up anyone with a taste for glitz and a wallet ready to act. This iconic jeweler, swinging its roots from a humble family biz to a global gem, is opening up its vault with an Inventory Reduction Sale starting October 9. And folks, it’s happening right at their Buckhead flagship showroom....

Boliden's Q3 2026 Results: What's on the Horizon?

Boliden Ready to Reveal Q3 Numbers Mark it down, folks. Thursday, October 29, 2026, is the day when Boliden's big wigs will step up to the plate and lay their cards on the table about the company's performance over the last quarter. If you've got any skin in this mining powerhouse, you'll want a front-row seat—or at least a virtual one if you're dialing in from...

Steel Dynamics Gears Up for Q3 2026 Earnings Update

Steel Dynamics Preps for Key Earnings Report Folks, we're staring down the barrel of another quarterly earnings report from Steel Dynamics, Inc., and you can bet this one is gonna have plenty of eyes glued. October 19th, 2026, that's when they'll peel back the curtain on how they fared in Q3. Now, buckle up, because this isn't just a numbers game—it’s a snapshot of...

Moore, Schulman & Moore Attorneys Earn Top Honors Again

In the realm of family law, consistency in excellence matters just as much as landing a high-stakes stock trade. Moore, Schulman & Moore, APC, a San Diego family law outfit, has grabbed the spotlight yet again with nine of its ace attorneys snagging recognition from the 2027 Super Lawyers roster. A Tradition of Professional Recognition Leading the pack is Erik Moore, a...

STRATA Showcases Excimer Laser Success in Dermatology

The Cutting Edge of Skin Care: STRATA's Spotlight It's not every day you hear about dermatology shaking things up, but STRATA Skin Sciences, Inc. pulled it off with flair at the 2026 Fall Clinical Dermatology Conference in Las Vegas. For 'skin in the game,' these folks are leading the charge with their innovative excimer laser phototherapy approach, shining a fresh light...

Ajman Tourism Department Hits Internal Audit Milestone

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Caitlyn Brazill Takes Helm at Per Scholas: CEO Transition

Caitlyn Brazill named CEO, marking a leadership shift Call this one a big baton pass in the world of workforce development. Caitlyn Brazill is stepping into the role of CEO and President at Per Scholas, effective January 1, 2027. She'll be filling the rather large shoes of Plinio Ayala, the man who's been steering the ship since its days in the Bronx, growing it into a...